Mediar Therapeutics
Health Care · Biotechnology
Lately:1 news story in 90 daysFollow changes →
Facts
as of Nov 20, 2026New perspective. Novel targets. Clinical trials. The myofibroblast is responsible for depositing collagen, extracellular matrix, and maintaining the pro-fibrotic micro-environment in organ systems. By deactivating the myofibroblast, we hope to slow fibrosis and possibly reverse it.
- Employees
- 51-200estimated range
- Website
- mediartx.com
These are the key facts about Mediar Therapeutics on Alion as of Nov 20, 2026. The latest round is Series B of $76M, announced in 2026.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
Funding
Full ledger, 1 record →Mediar Therapeutics has $76M paid in by investors, lenders and donors.
$76MPaid in
Money innewest first
$76MPaid
Money by yearUSD, rounds and grants
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
Ownership
All holders and entities →Sources name ICG, Amplitude Ventures among the owners or investors of Mediar Therapeutics.
Named investors, no share stated2
Holders and shares as each register or filing states them.
Products
Products →Mediar Therapeutics has 6 clinical trials on record, 3 under way.
Clinical trials
Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease
phase 1 · under way · 88 participants · Healthy Adult Participants; Diabetic Kidney Disease
May 2026
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
phase 2 · under way · 85 participants · Diffuse Cutaneous Systemic Sclerosis
Apr 2026
Evaluation of MTX-463 Administered Subcutaneously in Healthy Adult Males
phase 1 · completed · 8 participants · Healthy Adult Male
Feb 2026
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
Milestones
Raised a round Series B $76M · led by Amplitude Ventures · YahooFinance
Jan 7
Website went live first capture in the Wayback Machine
Sep 2019
Sources: the outlets named on each headline, each story once
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
